Long GnRH agonist vs. GnRH antagonist protocol in randomized controlled trial in unselected patients - Hormonal and cycle characteristics - Pilot study;Randomizované srovnání dlouhého GnRH agonistického vs. GnRH antagonistického protokolu - Hormonální parametry a charakteristiky cyklů - Pilotní studie

Ceska Gynekologie

Volumn 74, Issue 2, 2009, Pages 75-80

  Streda R ^a   Mardesic T ^a   Sobotka, V ^a   Tosner J ^b  

^a Sanatorium Pronatal   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Estradiol; Follitropin beta; Gonadotropins; ICSI; IVF; OHSS; Ovulation induction

Indexed keywords

CETRORELIX; DRUG DERIVATIVE; ESTRADIOL; GONADORELIN; HORMONE ANTAGONIST; LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; FEMALE; HUMAN; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; TRIPTORELIN; YOUNG ADULT;

EID: 67649496528     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Comparable clinical outcome using the GnRH antagonist ganire-lix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod, 2001, 16, p. 644-651.
2. Aboulghar, MA., Mansour, RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update, 2003, 9, p. 275-289.
3. Asch, RH., Li, HP., Balmaceda, JP., et al. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod, 1991, 6, p. 1395-1399.
4. Borm, G., Mannaerts, B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod, 2000, 15, p. 1490-1498.
5. Brinsden, PR. A textbook of In Vitro Fertilization and Assisted Reproduction. New York: Parthenon Publishing, 1999, p. 131-155.
6. Daya, S. Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane. Database. Syst. Rev, 2007, CD001299.
7. Gardner, DK., Weissman, A., Howies, CM., et al. Textbook of Assisted Reproductive Techniques. London: Martin Dunitz, 2001, p. 464-469.
8. Griesinger, G., Diedrich, K., Devroey, P., et al. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and metaanalysis. Hum Reprod Update, 2006, 12, p. 159-168.
9. Haning, RV., Austin, CW., Carlson, IH., et al. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril, 1983, 40, p. 31-36.
10. Kolibianakis, S. Agonists and Antagonists. Besins Healthcare, 2007, p. 38-42.
11. Koryntová, D. Indukce ovulace a kontrolovaná ovariální hypers-timulace. Mod gynek porod, 2002, 11, s. 525-530.
12. Mardešič, T. Indikace a výsledky léčby sterility metodami asistované reprodukce. Mod gynek porod, 2002, 11, s. 565-571.
13. Meirow, D., Schenker, JG., Rosier, A. Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17 alpha-hydro-xylase, 17, 20-lyase deficiency: what is the role of oestrogens? Hum Reprod, 1996, 11, p. 2119-2121.
14. Morris, RS., Paulson, RJ., Sauer, MV., et al. Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum Reprod, 1995, 10, p. 811-814.
15. Ragni, G., Vegetti, W., Riccaboni, A., et al. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod, 2005, 20, p. 2421-2425.
16. Rizk, B., Aboulghar, M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod, 1991, 6, p. 1082-1087.
17. Rizk, B., Smitz, J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum Reprod, 1992, 7, p. 320-327.
18. Tortoriello, DV., McGovern, PG., Colon, JM., et al. Critical ovarian hyperstimulation syndrome in a coasted in-vitro fertilization patient. Hum Reprod, 1998, 13, p. 3005-3008.
19. Zikopoulos, K., Kaponis, A., Adonakis, G. A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin- releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermie. Fertil Steril, 2009, 83, p. 1354-1362.